Opioid manufacturer Purdue Pharma has agreed to plead guilty to three criminal charges as part of a settlement of more than $8 billion. The agreement doesn’t include the criminal release of the company’s executives or owners
Thirty-three million Medicare beneficiaries will receive a discount card in the mail for $200 that can be used to help pay for prescription drugs, President Trump said Sept. 24. However, a consumer group said Trump’s bizarre announcement is a transparent and pathetic attempt to bribe seniors for their votes.
In Washington state, the primary election is Tuesday. Last week, I voted on the ballot send to me in the mail, then I took it to the drop box about 10 blocks from my house. I’m a big fan of our state’s vote-by-mail system.
Unable to come to an agreement with Congress on how to curb rising prescription drug prices, President Donald Trump announced four executive orders last week that he said would lower prescription drug prices to American consumers.
Big pharmaceutical corporations, including Gilead, Pfizer, and GlaxoSmithKline, have hiked the prices of more than 250 prescription drugs as of Jan. 1. Annual and biannual price increases on medicines have become a standard practice of brand-name pharma corporations.
As usual, most of the end-of-the-year, round-up articles are about national issues or corporations. If consumers are mentioned, it’s usually about how they’re responding to some corporation. For the most part, it’s been a grim year for consumers.
Corporations keep breaking the law, and the Department of Justice keeps refusing to prosecute them, a report finds. The DOJ’s refusal to bring criminal prosecutions against big banks, big pharma, and other big businesses has led to a failure to deter repeat offenders.
Photo: JJBers CVS-Aetna lawyers, consumer advocates, and health care organizations gathered Thursday in Washington, D.C., for oral arguments on whether
There are three essential elements to a strategy to get the lowest prescription prices: Lawmakers need to: increase public negotiating power, curb the abuse of monopoly power, and block year-to-year prescription spikes.
